Skip to main navigation
Skip to search
Skip to main content
Arizona Board of Regents Home
Home
Profiles
Departments and Centers
Scholarly Works
Grants
Activities
Equipment
Datasets
Press/Media
Prizes
Search by expertise, name or affiliation
MAb Therapeutics against West Nile Virus with Improved CNS Penetration
Qiang Chen
(Inventor)
Arizona State University
Research output
:
Patent
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'MAb Therapeutics against West Nile Virus with Improved CNS Penetration'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
West Nile Virus
100%
Blood-Brain Barrier
42%
Virus Infection
28%
Monoclonal Antibody
28%
Combination Therapy
14%
Neurologic Disease
14%
Clinical Trial
14%
Antivirus Agent
14%
Flavivirus Infection
14%
Flavivirus
14%
Immunology and Microbiology
West Nile Virus
100%
Blood Brain Barrier
42%
Viral Disease
28%
Vaccine Efficacy
28%
Monoclonal Antibody
28%
Flavivirus
28%
Keyphrases
CNS Penetration
100%
Treatment Window
40%
Long-term Morbidity
20%
Extended Treatment
20%
Medicine and Dentistry
Flavivirus Infection
14%
Flavivirus
14%